Navigation Links
Breast Cancer Funding To Be Extended By Another $30 Million: Pharmac

It has been proposed by Pharmac, to hold a meeting regarding extension of funding for the cancer drug Herceptin that would allow the provision of drug to women with early breast cancer. // Currently, funding can only be availed by patients with advanced breast cancer. Extension of the budget for the cancer from the existing $47 million to $77 million has been planned.

The company officials are much more bothered about the safety and efficacy of the anti-cancer drug that is being assessed, according to Dr Peter Moodie, Medical Director, Pharmac. He further stated that the company officials are being open minded about the issue and are really interested in the drug.

The authorization body, Medsafe is yet to approve the proposal of the Pharmac's Pharmacology Therapeutics Advisory Committee.

HER2 positive cancers, an aggressive form account for 30% of all breast cancers against which Herceptin has been shown to be effective. Although previous studies have been able to demonstrate a 46% improved survival rate in those who received the drug and a decreased recurrence rate, the cost constraint has limited widespread use of drug.

Libby Burgess, Chairwoman, Breast Cancer Advocacy Coalition is very hopeful that a lot of valuable lives can be saved by the investment. Most women in New Zealand face severe financial constraints to enable breast cancer treatment. In fact, some even go to the extent of mortgaging their house. Nearly 2500 women in New Zealand are being diagnosed with breast cancer every year.

Pharmac and Roche Products are locally supplying the anti-cancer drug in New Zealand. The pharmaceutical companies are closely working together to extend the available funding. A spokesman for Roche announced that the assessment process is being fast-tracked.


'"/>




Page: 1

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast cancer treatment to be determined by gene test
3. Breast Feeding prevents obesity later on in life
4. Breast milk is essential
5. Breast Cancer Surgery Causes Psychological problems
6. Breast cancer evidence
7. Letrozole Beats Tamoxifen in Breast Cancer Therapy
8. Breast screening among diabetic women
9. Breast feeding can alter hormones
10. Diet, Sunlight connected to Breast Cancer Risk
11. Additional Radiotheraphy for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2016)... ... February 08, 2016 , ... Steve Helwig & Associates ... vital new community enrichment program, has teamed up with Citizens Opposed to Domestic Abuse ... from intimate abuse. To support all those victimized by the fear of violence in ...
(Date:2/8/2016)... , ... February 08, 2016 , ... Delta Dental of ... help combat pancreatic cancer. , Gary D. Radine, who recently retired as president and ... American Cancer Society’s 2015 CEO of the Year , helped lead the effort ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... While a significant number of women and men with eating disorders report a ... that best predicts the development of an eating disorder. , At the ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... than 50% lower incidence rate of type 2 diabetes in the GrassrootsHealth cohort ... is time to make a change in public health,” states Carole Baggerly, Director ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... speaking on how healthcare companies can use newly released government data on populations ... a population and intervene and capture the value they create to succeed in ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... -- A research team led by St. Jude Children,s ... the abnormal breakage and rearrangement of chromosomes in white ... lymphoblastic leukemia (ALL). Such leukemias are cancers of white ... immature cells, called lymphoblasts. --> ... the type called "Ph-like ALL" will aid in designing ...
(Date:2/8/2016)... PALO ALTO, Calif. , Feb. 8, 2016 ... chemical manufacturing, and Kodiak Sciences Inc., a biopharmaceutical company ... retinal disease, announced today agreements for the clinical supply ... manufacture material at multiple sites, including Slough (UK), Visp ... --> Retinal diseases, such as age-related ...
(Date:2/8/2016)... 2016  The University of Michigan Health System in ... as part of the development of four new operating ... in the U.S. to start using new top-of-the-line neurosurgical ... chair of neurosurgery. --> Karin Muraszko ... The BrightMatter technology from Synaptive Medical – a ...
Breaking Medicine Technology: